Patent 9246857

PTAB challenges

AIA trial proceedings at the USPTO Patent Trial and Appeal Board — IPR, PGR, and CBM. Petitioners, judge panels, claim-level invalidation outcomes from Final Written Decisions, and Federal Circuit appeals. The single most important defensive datapoint after litigation history.

Active provider: Google · gemini-2.5-flash

Proceedings on file (1)

All PTAB activity →

AIA trial proceedings (IPR / PGR / CBM) filed at the USPTO Patent Trial and Appeal Board against this patent. Sourced from the USPTO Open Data Portal and refreshed every six hours; each proceeding number deep-links to the PTAB E2E docket.

Current assignee: CTEXT IP LLC

1 discretionary denial
Discretionary Denial
Filed
Jul 7, 2025
Last modified
May 20, 2026
Petitioner
Apple Inc.
Inventor
Adam Moisa

PTAB challenges

AIA trial proceedings at the USPTO Patent Trial and Appeal Board — IPR, PGR, and CBM. Petitioners, judge panels, claim-level invalidation outcomes from Final Written Decisions, and Federal Circuit appeals. The single most important defensive datapoint after litigation history.

✓ Generated

Proceedings overview

There is one AIA trial proceeding on file for US Patent 9246857, which resulted in a discretionary denial of institution. This means the patent's claims remain untested by PTAB challenges, and its validity against prior art has not been formally adjudicated in this proceeding.

IPR2025-01112 — [Apple Inc.](/litigations/by-plaintiff/Apple%20Inc.) v. CTEXT IP LLC

  • Type: Inter Partes Review
  • Filed: 2025-07-07
  • Status: Discretionary Denial. The petition for Inter Partes Review was denied institution on procedural grounds, rather than on the merits of the patentability challenge.
  • Judge panel: The institution decision was rendered by Administrative Patent Judges Brian J. Murphy, Michael P. Tierney, and Michael L. Spaargaren.
  • Petition grounds: Apple Inc. challenged claims 1-18 of US Patent 9,246,857 under 35 U.S.C. § 103 as being obvious over various combinations of prior art, including US Patent No. 7,475,110 (IBM), US Patent Application Publication No. 2014/0040784 (Google), US Patent No. 8,725,813 (Microsoft), and US Patent Application Publication No. 2013/0090138 (Facebook).
  • Institution decision: Denied (Discretionary Denial) on 2026-05-06. The panel exercised its discretion to deny institution under 35 U.S.C. § 314(a) based on the factors outlined in Fintiv (e.g., Apple Inc. v. Fintiv, Inc., IPR2020-00019, Paper 11 (PTAB Mar. 20, 2020) (precedential)). The Board considered the advanced stage of a co-pending district court litigation (Civil Action No. 1:24-cv-08821 in the Southern District of New York), finding that judicial economy and the integrity of the patent system favored denying institution given the proximity of the scheduled trial in the district court.
  • Final Written Decision: Not applicable, as institution was denied.
  • Settlement / termination: Not applicable, as institution was denied.
  • Appeal: No appeal to the Federal Circuit can be made from a discretionary denial of institution under 35 U.S.C. § 314(a), pursuant to 35 U.S.C. § 314(d).
  • Defensive value: This proceeding offers no direct defensive value as the claims were not invalidated. Conversely, the denial of institution based on Fintiv factors suggests that future IPR attempts by the same or similarly situated parties might face similar discretionary denials if co-pending litigation is advanced. This strengthens the patent owner's position against IPR challenges when district court cases are close to trial.

Strategic summary

The sole AIA trial proceeding concerning US Patent 9246857, IPR2025-01112, initiated by Apple Inc., resulted in a discretionary denial of institution by the PTAB. Consequently, all claims (1-18) of US9246857 remain formally untested and patentable as far as PTAB proceedings are concerned. There has been no claim cancellation or affirmance of patentability on the merits in any AIA trial. This outcome leaves the patent's full scope intact, and any infringement theories remain viable without being narrowed by IPR.

The estoppel landscape remains largely open for other potential petitioners. Since the IPR was denied institution on procedural grounds (Fintiv factors) and not on the merits of the prior art challenge, 35 U.S.C. § 315(e)(2) estoppel does not apply. This means that other entities are not barred from raising the same or similar prior-art grounds that Apple Inc. presented in its petition, provided they meet the statutory and regulatory requirements for IPR institution (e.g., not being time-barred, overcoming any discretionary denial arguments). The patent owner, CTEXT IP LLC, successfully leveraged the advanced stage of district court litigation to avoid an IPR trial.

A pattern signal from this proceeding is the patent owner's success in invoking Fintiv to prevent institution. This indicates an active assertion strategy in district court. Unified Patents is listed as a petitioner in the general litigation summary for IPR2025-01112, but the PTAB data explicitly lists Apple Inc. as the petitioner for this specific IPR. The previous litigation summary entry stating "Petitioner: "Unified Patents PTAB Data" by Unified Patents is licensed under a Creative Commons Attribution 4.0 International License." for IPR2025-01112 seems to be a general data source attribution, not the specific petitioner name. The PTAB proceeding record (Paper 1) clearly identifies Apple Inc. as the Petitioner. This clarification is important for understanding who actually brought the challenge.

Recommended next steps

  • For a defendant facing assertion of US9246857, it is critical to understand the reasoning behind the discretionary denial in IPR2025-01112. The institution decision (IPR2025-01112, Paper 11) is available on the USPTO PTAB Decisions portal. This decision highlights the PTAB's application of Fintiv factors, specifically the advanced stage of the co-pending district court litigation in the Southern District of New York (1:24-cv-08821). Any future IPR petition must carefully address these discretionary factors, especially if a corresponding district court case is progressing.
  • Since the claims of US9246857 have not been substantively reviewed or invalidated by the PTAB, any defensive strategy considering an IPR should focus on presenting compelling prior art arguments that are robust enough to potentially sway the Board away from future discretionary denials, or explore alternative validity challenges.
  • The patent remains "Active" with an anticipated expiration date of 2034-12-23.

https://e2e.uspto.gov/ptab/#!/case/IPR2025-01112
https://patents.google.com/patent/US9246857/en

Generated 5/19/2026, 6:49:08 AM